AHA Moments – September 1, 2026

New Hampshire residents selected at random may receive a call throughout the year to participate in the annual Behavioral Risk Factor Surveillance Survey (NH BRFSS), a confidential 20 to 25-minute survey about health and well-being. Your responses help shape health programs and policies, from guiding physical activity and arthritis interventions to evaluating differences in access to care and health outcomes across rural and non-rural communities.

AARP New Hampshire is hiring for a Community Outreach and Communications Intern. The team creates and executes various events and projects to improve people’s lives as they age and help build a better tomorrow for future generations. This paid internship has an anticipated start date of Fall 2026 and will run through the end of the year, with the possibility of extending additional semesters.

Housing professionals, developers, policymakers, business leaders, and community partners from across New Hampshire will gather on September 23 in Concord for a conversation about the people, places, and ideas shaping the state’s housing future. This year’s conference will explore historic preservation and adaptive reuse, the workforce needed to meet housing demand, and innovative strategies to strengthen communities and the economy.

The National Rural Health Association is co-hosting a virtual briefing on September 9 focused on how rural health systems can better support older adults and family caregivers. The session will feature research, lived-experience insights, and practical resources for strengthening rural health, caregiving, long-term services and supports, and cross-sector collaboration.

The National Center to Reframe Aging will present Summit 2026: The Movement to Reframe Aging on September 16, bringing together thought leaders, national experts, federal representatives, and leaders from across sectors to explore how we communicate, think, and act on aging. Building on more than a decade of research and the momentum of the inaugural 2024 Summit, the event will examine how communities and organizations can help advance healthier, more age-inclusive communities.

The U.S. Food and Drug Administration (FDA) has cleared another blood test to help identify signs of Alzheimer’s disease in people 55 and older living with cognitive decline. The clearance comes as ⁠drugmakers and diagnostic companies race to develop simpler tests for Alzheimer’s to accelerate earlier diagnosis and treatment, which is important because disease-modifying treatments have the greatest impact at earlier stages.